Spragens Jeffrey G 4
4 · SAB Biotherapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
Spragens Jeffrey G
Director
Transactions
- Other
Common Stock
2022-05-20+299,002→ 312,002 total
Footnotes (1)
- [F1]The Reporting Person received 207,001 shares as part of a pro-rata distribution by Big Cypress Holdings LLC, which the Reporting Person is a limited partner of, of which shares he previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.